Docuchem supports Hemmo Pharmaceutical's developments on the manufacturing of Peptides in it's Navi Mumbai facility since 2006. Docuchem continues to design synthetic paths for generic and custom peptides to be manufactured in India by Hemmo Pharmaceuticals.
The Navi Mumbai facility was awarded a GMP compliance certificate from the German Authorities after an inspection of the Hamburg branch back in 2010.
In march 2011, Hemmo Pharmaceuticals received a Preapproval Inspection from the USFDA for desmopressin and Oxytocin and received the letter classifying the facility as acceptable in June 2011.
The facility manufactures under GMP compliance a range of generic as well as proprietary peptides for the indian as well as foreing markets and continues to be one of the key players in the manufacturing of oxytocin worldwide.